Comparison of the behavioral and cardiovascular effects of intranasal and oral d-amphetamine in healthy human subjects

Journal of Clinical Pharmacology

Volumn 51, Issue 6, 2011, Pages 888-898

  Lile, Joshua A ^a   Babalonis, Shanna ^b   Emurian, Cleeve ^a   Martin, Catherine A ^a   Wermeling, Daniel P ^c   Kelly, Thomas H ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c University of Kentucky   (United States)

Author keywords

balloon analog risk task; d Amphetamine; delay discounting; digit symbol substitution task; intranasal; subjective

Indexed keywords

DEXAMPHETAMINE;

ADULT; ARTICLE; BEHAVIOR; BLOOD PRESSURE; CARDIOVASCULAR EFFECT; DOUBLE BLIND PROCEDURE; FEMALE; HEART RATE; HUMAN; HUMAN EXPERIMENT; MALE; NEBULIZATION; NORMAL HUMAN; QUESTIONNAIRE; SELF REPORT; TASK PERFORMANCE;

ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ADULT; BLOOD PRESSURE; CENTRAL NERVOUS SYSTEM STIMULANTS; DEXTROAMPHETAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART RATE; HUMANS; IMPULSIVE BEHAVIOR; MALE; NEBULIZERS AND VAPORIZERS; PSYCHOMOTOR PERFORMANCE; SELF REPORT; TIME FACTORS;

EID: 79955835476     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/0091270010375956     Document Type: Article

References (37)

1. Wermeling D. Intranasal delivery of antiepileptic medications for treatment of seizures. Neurotherapeutics. 2009 ; 6: 352-358
2. Comer SD, Ashworth JB, Sullivan MA, Vosburg SK, Saccone PA, Foltin RW. Relationship between rate of infusion and reinforcing strength of oxycodone in humans. J Opioid Manag. 2009 ; 5: 203-212
3. Wee S, Carroll FI, Woolverton WL. A reduced rate of in vivo dopamine transporter binding is associated with lower relative reinforcing efficacy of stimulants. Neuropsychopharmacology. 2006 ; 31: 351-362 (Pubitemid 43113399)
4. Winger G, Hursh SR, Casey KL, Woods JH. Relative reinforcing strength of three N-methyl-D-aspartate antagonists with different onsets of action. J Pharmacol Exp Ther. 2002 ; 301: 690-697 (Pubitemid 34429985)
5. Anderson KG, Woolverton WL. Effects of dose and infusion delay on cocaine self-administration choice in rhesus monkeys. Psychopharmacology. 2003 ; 167: 424-430 (Pubitemid 36754245)
6. Kelly TH, Foltin RW, Emurian CS, Fischman MW. Effects of delta 9-THC on marijuana smoking, dose choice, and verbal report of drug liking. J Exp Anal Behav. 1994 ; 61: 203-211
7. Wilens TE, Adamson J, Monuteaux MC, et al. Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents. Arch Pediatr Adolesc Med. 2008 ; 162: 916-921
8. Berman SM, Kuczenski R, McCracken JT, London ED. Potential adverse effects of amphetamine treatment on brain and behavior: a review. Mol Psychiatry. 2009 ; 14: 123-142
9. Safer DJ, Zito JM, Fine EM. Increased methylphenidate usage for attention deficit disorder in the 1990s. Pediatrics. 1996 ; 98: 1084-1088 (Pubitemid 26399270)
10. Setlik J, Bond GR, Ho M. Adolescent prescription ADHD medication abuse is rising along with prescriptions for these medications. Pediatrics. 2009 ;:
11. Zito JM, Safer DJ, dosReis S, Gardner JF, Boles M, Lynch F. Trends in the prescribing of psychotropic medications to preschoolers. JAMA. 2000 ; 283: 1025-1030 (Pubitemid 30112216)
12. Stoops WW, Glaser PE, Rush CR. Reinforcing, subject-rated, and physiological effects of intranasal methylphenidate in humans: a dose-response analysis. Drug Alcohol Depend. 2003 ; 71: 179-186 (Pubitemid 37289027)
13. Martin WR, Sloan JW, Sapira JD, Jasinski DR. Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther. 1971 ; 12: 245-258
14. Oliveto AH, Bickel WK, Hughes JR, Shea PJ, Higgins ST, Fenwick JW. Caffeine drug discrimination in humans: acquisition, specificity and correlation with self-reports. J Pharmacol Exp Ther. 1992 ; 261: 885-894
15. McLeod DR, Griffiths RR, Bigelow GE, Yingling JE. An automated version of the digit symbol substitution test (DSST). Behav Res Methods Instr. 1982 ; 14: 463-466
16. Lejuez CW, Read JP, Kahler CW, et al. Evaluation of a behavioral measure of risk taking: the Balloon Analogue Risk Task (BART). J Exp Psychol Appl. 2002 ; 8: 75-84
17. Mazur JE Quantitative analyses of behavior: the effects of delay and of intervening events on reinforcement value. Commons ML Mazur JE Nevin JA Rachlin H, ed. Hillsdale, NJ: Erlbaum Associates ; 1987 1987: 55-73.
18. Stoops WW, Lile JA, Robbins CG, Martin CA, Rush CR, Kelly TH. The reinforcing, subject-rated, performance and cardiovascular effects of d-amphetamine: influence of sensation-seeking status. Addict Behav. 2007 ; 32: 1177-1188 (Pubitemid 46497548)
19. Kelly TH, Foltin RW, Fischman MW. The effects of repeated amphetamine exposure on multiple measures of human behavior. Pharmacol Biochem Behav. 1991 ; 38: 417-426
20. Lile JA, Stoops WW, Durell TM, Glaser PE, Rush CR. Discriminative- stimulus, self-reported, performance, and cardiovascular effects of atomoxetine in methylphenidate-trained humans. Exp Clin Psychopharmacol. 2006 ; 14: 136-147 (Pubitemid 43988631)
21. Lile JA, Kendall SL, Babalonis S, Martin CA, Kelly TH. Evaluation of estradiol administration on the discriminative-stimulus and subject-rated effects of d-amphetamine in healthy pre-menopausal women. Pharmacol Biochem Behav. 2007 ; 87: 258-266 (Pubitemid 46963359)
22. Sevak RJ, Stoops WW, Hays LR, Rush CR. Discriminative stimulus and subject-rated effects of methamphetamine, d-amphetamine, methylphenidate, and triazolam in methamphetamine-trained humans. J Pharmacol Exp Ther. 2009 ; 328: 1007-1018
23. Stoops WW, Lile JA, Glaser PE, Rush CR. Discriminative stimulus and self-reported effects of methylphenidate, d-amphetamine, and triazolam in methylphenidate-trained humans. Exp Clin Psychopharmacol. 2005 ; 13: 56-64 (Pubitemid 40261830)
24. Jasinski DR, Krishnan S. Human pharmacology of intravenous lisdexamfetamine dimesylate: abuse liability in adult stimulant abusers. J Psychopharmacology. 2009 ; 23: 410-418
25. Kahn DA, Prohovnik I, Lucas LR, Sackeim HA. Dissociated effects of amphetamine on arousal and cortical blood flow in humans. Biol Psychiatry. 1989 ; 25: 755-767 (Pubitemid 19101992)
26. Angrist B, Corwin J, Bartlik B, Cooper T. Early pharmacokinetics and clinical effects of oral d-amphetamine in normal subjects. Biol Psychiatry. 1987 ; 22: 1357-1368 (Pubitemid 18046652)
27. Asghar SJ, Tanay VA, Baker GB, Greenshaw A, Silverstone PH. Relationship of plasma amphetamine levels to physiological, subjective, cognitive and biochemical measures in healthy volunteers. Hum Psychopharmacol. 2003 ; 18: 291-299 (Pubitemid 36722315)
28. Brauer LH, Ambre J, De Wit H. Acute tolerance to subjective but not cardiovascular effects of d-amphetamine in normal, healthy men. J Clin Psychopharmacol. 1996 ; 16: 72-76
29. Costantino HR, Illum L, Brandt G, Johnson PH, Quay SC. Intranasal delivery: physicochemical and therapeutic aspects. Int J Pharm. 2007 ; 337: 1-24 (Pubitemid 46756063)
30. Wermeling DP, Miller JL, Archer SM, Manaligod JM, Rudy AC. Bioavailability and pharmacokinetics of lorazepam after intranasal, intravenous, and intramuscular administration. J Clin Pharmacol. 2001 ; 41: 1225-1231 (Pubitemid 32983221)
31. Arria AM, Caldeira KM, O'Grady KE, Vincent KB, Johnson EP, Wish ED. Nonmedical use of prescription stimulants among college students: associations with attention-deficit-hyperactivity disorder and polydrug use. Pharmacotherapy. 2008 ; 28: 156-169 (Pubitemid 351206963)
32. Dupont RL, Coleman JJ, Bucher RH, Wilford BB. Characteristics and motives of college students who engage in nonmedical use of methylphenidate. Am J Addict. 2008 ; 17: 167-171 (Pubitemid 351883180)
33. McCabe SE, Teter CJ. Drug use related problems among nonmedical users of prescription stimulants: a web-based survey of college students from a Midwestern university. Drug Alcohol Depend. 2007 ; 91: 69-76 (Pubitemid 47385032)
34. Coetzee M, Kaminer Y, Morales A. Megadose intranasal methylphenidate (ritalin) abuse in adult attention deficit hyperactivity disorder. Subst Abus. 2002 ; 23: 165-169 (Pubitemid 37087324)
35. Garland EJ. Intranasal abuse of prescribed methylphenidate. J Am Acad Child Adolesc Psychiatry. 1998 ; 37: 1242-1243
36. Jaffe SL. Intranasal abuse of prescribed methylphenidate by an alcohol and drug abusing adolescent with ADHD. J Am Acad Child Adolesc Psychiatry. 1991 ; 30: 773-775
37. Hart CL, Gunderson EW, Perez A, et al. Acute physiological and behavioral effects of intranasal methamphetamine in humans. Neuropsychopharmacology. 2008 ; 33: 1847-1855 (Pubitemid 351832594)